You are here

Responses

Article menu
Download PDFPDF
Editorial
Prioritising paediatric surveillance during the COVID-19 pandemic
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 22 June 2021
    Protect children from Covid-19: the “secondary pandemia”
    • Federico Marchetti, Director, Pediatrician Department of Paediatrics, Santa Maria delle Croci Hospital, 48121 Ravenna, Italy

    Dear Editor,
    Ladhani SN et al (1) underline during the pandemic from Covid-19 the importance of reporting pediatric population surveillance data, and the pediatricians are encouraged to get involved with research and clinical trials to better understand the immunopatho-physiology and identify effective treatments for COVID-19 in children.

    However, as the authors themselves point out, the Covid-19 pandemic has been shown to be much milder as clinical manifestations in the infant and child than in the adult. Bhopal S et al (2) examined mortality data for 0-19 year olds, showing that across France, Germany, Italy, Korea, Spain, the United Kingdom, and the United States there were 44 deaths from covid-19 in 0-19 year olds (total population 135.691.226) up to 19 May 2020. Over a normal three month period, in these countries, published Global Burden of Disease data estimate that more than 13.000 deaths would be expected from all causes in this age group, including over 1000 from unintentional injury and 308 from lower respiratory tract infection including influenza.

    Because of their isolation, children are having documented risks that we are getting used to calling Covid-19 side effects or secondary pandemic (3,4): from delays in diagnosing some clinically relevant diseases (5), to educational deprivation (6), to the care needs of certain categories of children fragile with social and health needs that have interrupted their care project. The deep risk that...

    Show More
    Conflict of Interest:
    None declared.